Atlas Trials

Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.

Clinical trial NCT07371325 · COMPLETED

Trial details

NCT number
NCT07371325
Sponsor
Manuel Jesús Cuesta Zurita
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
SCHIZOPHRENIA 1 (Disorder)Metabolic AbnormalitiesPostbiotic Supplement
Start date
2024-09-08
Primary completion
2026-01-23
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.